Tran, Jonathan Q. http://orcid.org/0000-0002-7187-7307
Zhang, Peijin
Ghosh, Atalanta
Liu, Liangang
Syto, Mary
Wang, Xiaomin
Palmisano, Maria
Clinical trials referenced in this document:
Documents that mention this clinical trial
Single-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites Alone and in Combination with Gemfibrozil, Itraconazole, or Rifampin in Healthy Subjects: A Randomized, Parallel-Group, Open-Label Study
https://doi.org/10.1007/s12325-020-01473-0
Funding for this research was provided by:
This study was funded by Celgene Corporation. Editorial assistance was provided by Peloton Advantage, LLC, an OPEN Health company, with funding from Bristol-Myers Squibb Company.
Article History
Received: 8 July 2020
First Online: 28 August 2020